Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables
about
S-adenosyl-L-methionine for alcoholic liver diseasesPropylthiouracil for alcoholic liver diseasePentoxifylline for alcoholic hepatitisMilk thistle for alcoholic and/or hepatitis B or C virus liver diseasesAnabolic-androgenic steroids for alcoholic liver diseasePropylthiouracil for alcoholic liver diseaseS-adenosyl-L-methionine for alcoholic liver diseasesGlucocorticosteroids for people with alcoholic hepatitisAcute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statementAlcoholic hepatitis: a comprehensive review of pathogenesis and treatmentTherapy for alcoholic liver diseaseMeta-analysis of propylthiouracil for alcoholic liver disease--a Cochrane Hepato-Biliary Group Review.Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis.Predicting short-term mortality and long-term survival for hospitalized US patients with alcoholic hepatitis.Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy.Treatment of alcoholic hepatitis.Treatment of decompensated alcoholic liver disease.Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review.Molecular targets in the treatment of alcoholic hepatitis.Management of alcoholic hepatitis: Current concepts.Current concepts and controversies in the treatment of alcoholic hepatitis.Treatment of severe forms of alcoholic hepatitis: where are we going?Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial.KASL clinical practice guidelines: management of alcoholic liver diseaseAssessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis.Practical Concerns and Controversies in the Management of Alcoholic Hepatitis.Pharmacotherapy of acute alcoholic hepatitis in clinical practice.Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury.Autoantibodies in alcoholic liver disease.Alcoholic hepatitis: diagnosis and management in 2012.Prognosis and treatment of patients with acute alcoholic hepatitis.Alcoholic hepatitis: The pivotal role of Kupffer cells.Alcoholic Hepatitis: Risk Factors, Pathogenesis, and Approach to Treatment.The integration of medical management with recovery.[Management of severe alcoholic hepatitis].The impact of specialist management of jaundiced alcoholic liver disease patients.Glucocorticosteroids for people with alcoholic hepatitis.Alcoholic liver disease.Alcoholic hepatitis.
P2860
Q24188041-564752AB-A186-42D1-AA87-5780544A5CA0Q24236315-18039121-92C0-436F-96B9-402C715F1835Q24240223-A33C7BB7-9520-431C-BCAC-EF93EE8F9C9EQ24243006-6314C7F0-7F1D-432A-A759-FF50676F287AQ24244334-4D25E359-3143-4D11-986C-CEC17CA3432CQ24245565-27F8EF6D-4F29-43E2-B173-26E79DAC6F31Q24246175-440C38C8-F3CB-410E-9CB5-9D940052AA1FQ26471655-40867085-D762-453E-B03E-313D9803FB06Q26864487-A76DACBD-D4CD-48C6-8364-5FC8769A6F58Q27027418-AC230AC6-A64C-40CB-A0CE-F9D933B1D5E7Q28658193-56D67792-EB93-4ECE-B04E-E1746629B036Q31043549-0CF7212A-0CBB-4AF2-B513-0B8A0CC1322AQ33587538-552FAA73-3006-4422-A8F2-CB218C9BE2E2Q33783707-808D5856-80FA-4D45-91AC-86B9AE718AA2Q33807380-A97CE43D-6270-488B-8D5F-B9AE5DF402CDQ34213719-69261D9F-138E-405A-9736-5C4E1D9DC916Q34619396-5B140F52-0078-49BB-A626-2F0458F53AE7Q35207505-768C7E61-FA96-4198-AB74-9ED6FE4FDFF2Q36038296-A5AE6161-E067-4DC4-A4CA-404362563E9AQ36351877-8CCEBB57-622E-4420-9CD4-0F8F76264887Q36561560-D8038D07-0EF9-4FEF-ADEC-4EEBAD44CBC4Q36655119-05A46837-6D42-4840-A10C-A0F5E35E9E75Q37108881-0FFA49BA-0D43-4B83-ABEC-AF3B569F24BDQ37153909-5223BD8A-42E5-46C7-95EE-9B2FCB1F89B7Q37229858-99CA779F-0AA5-4F6A-81DD-5E2BC513955AQ37411328-B0A1B1F2-7FF7-4CA8-ACB8-FF44D9B0FBC5Q37421502-18E6E8CC-5D03-4199-9D4A-634BE362DC30Q37617944-152F5AD4-8CB5-4D02-9E7D-169B45EEC896Q37658702-100F957F-25E0-4DDB-BA47-D0ED036BCFF3Q37767452-E99009BD-5340-43BB-86DD-3E6272627E25Q38067131-690B1D2F-7561-408D-A561-29DD5385E270Q38203313-DF337218-CA71-4C5A-9EBF-DD1607D17F73Q38645785-E4EC76F0-3F2E-4131-8F41-30627B4031B2Q38721974-312069E5-6917-4F94-8FF7-4136CF121690Q41618800-D6185FBB-D107-435E-BA8B-9185AB6D02DEQ44181725-362B5F24-395B-4785-AB9C-43BFC1832FB2Q45088641-579D5466-12DD-41E4-B03D-A50F527C6D82Q47548940-A989E1D6-B98B-4859-A66F-7E3816F9E4D2Q51764048-746E43C9-B5BF-461E-BC46-CB7E6A9A8FF8Q51869184-EABD1B6A-1783-4080-9FCC-3EB6C69A605B
P2860
Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Glucocorticoids are ineffectiv ...... ting for confounding variables
@ast
Glucocorticoids are ineffectiv ...... ting for confounding variables
@en
Glucocorticoids are ineffectiv ...... ting for confounding variables
@nl
type
label
Glucocorticoids are ineffectiv ...... ting for confounding variables
@ast
Glucocorticoids are ineffectiv ...... ting for confounding variables
@en
Glucocorticoids are ineffectiv ...... ting for confounding variables
@nl
prefLabel
Glucocorticoids are ineffectiv ...... ting for confounding variables
@ast
Glucocorticoids are ineffectiv ...... ting for confounding variables
@en
Glucocorticoids are ineffectiv ...... ting for confounding variables
@nl
P2860
P356
P1433
P1476
Glucocorticoids are ineffectiv ...... ting for confounding variables
@en
P2093
Christensen E
P2860
P304
P356
10.1136/GUT.37.1.113
P407
P577
1995-07-01T00:00:00Z